Skip to content

Celldex 制药

US · CLDX #2630 按市值排名 上市于 1970
27.53 -1.40 -4.84%
实时 - 追踪5344个代码 - 心跳于482秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

增持
  • 最近一期（2026/Q3）披露持股的机构数量减少了1家。
  • 机构持股总比例上升了0.4个百分点。

机构持股

机构持股比例
110.83% +0.37pp
机构数量
303 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund70.69%
Hedge Fund27.93%
VC/PE Fund7.52%
Public Company2.84%
Insurance Company0.86%
Private Company0.58%
Government Pension Fund0.39%
Individual/Insider0.24%

主要股东 截至 2026-06-30

Wellington Management Group 12.15% · 9.54M 股
BlackRock 8.92% · 7.00M 股
Kynam Capital Management, LP 6.78% · 5.32M 股
T. Rowe Price Group, Inc. 5.97% · 4.69M 股
Vanguard Capital Management, LLC 5.12% · 4.02M 股
State Street Global Advisors 4.97% · 3.90M 股
FMR 4.74% · 3.72M 股
Deep Track Capital, LP 3.74% · 2.94M 股
Logos Global Management, L.P. 2.67% · 2.10M 股
Geode Capital Management, LLC 2.58% · 2.02M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 44次买入 · 6次卖出

姓名职务持股比例
Anthony Marucci Chief Executive Officer 0.05%
Sam Martin Senior VP, CFO, Secretary & Treasurer 0.04%
Freddy Jimenez General Counsel 0.04%
Richard Wright Chief Commercial Officer & Senior VP 0.03%
Ronald Pepin Chief Business Officer & Senior VP 0.03%
Margo Heath-Chiozzi Senior Vice President of Regulatory Affairs 0.02%
Elizabeth Crowley Chief Product Development Officer & Senior VP 0.01%
Tibor Keler Founder, Chief Scientific Officer & Executive VP 0.01%
Harry Penner Independent Director 0.00%
Karen Shoos Independent Chair of the Board of Directors 0.00%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-06-24 Harry Penner Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 Herbert Conrad Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 James Marino Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 Ronald Pepin Chief Business Officer & Senior VP Other Derivative Acquisition +20,000 $34.09
2026-06-24 Anthony Marucci Chief Executive Officer Other Derivative Acquisition +375,000 $34.09
2026-06-24 Tibor Keler Founder, Chief Scientific Officer & Executive VP Other Derivative Acquisition +115,000 $34.09
2026-06-24 Diane Young Senior VP & Chief Medical Officer Other Derivative Acquisition +57,000 $34.09
2026-06-24 Sarah Cavanaugh Senior Vice President of Corporate Affairs & Administration Other Derivative Acquisition +95,000 $34.09
2026-06-24 Garry Neil Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 Keith Brownlie Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 Cheryl Cohen Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 Elizabeth Crowley Chief Product Development Officer & Senior VP Other Derivative Acquisition +100,000 $34.09
2026-06-24 Rita Jain Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 Sam Martin Senior VP, CFO, Secretary & Treasurer Other Derivative Acquisition +93,000 $34.09
2026-06-24 Margo Heath-Chiozzi Senior Vice President of Regulatory Affairs Other Derivative Acquisition +95,000 $34.09
2026-06-24 Denice Torres Independent Director Other Derivative Acquisition +26,000 $34.09
2026-06-24 Freddy Jimenez General Counsel Other Derivative Acquisition +93,000 $34.09
2026-06-24 Teri Lawver SVP & Chief Commercial Officer Other Derivative Acquisition +90,000 $34.09
2026-01-01 Sam Martin Senior VP, CFO, Secretary & Treasurer Derivative Exercise and Retained +4,817 $10.38
2025-12-14 Ronald Pepin Chief Business Officer & Senior VP Derivative Exercise and Retained +19,333 $2.78–9.02

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:18 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Celldex 制药 讨论区 0 条评论

发表评论